Christèle Ossart

Residues in the Ligand Binding Domain That Confer Progestin or Glucocorticoid Specificity and Modulate the Receptor Transactivation Capacity

Catherine Robin-Jagerschmidt, Jean‐Marie Wurtz, Benoı̂t Guillot et al. · Molecular Endocrinology · 2000 · 35 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

Identification of SLAMF3 (CD229) as an Inhibitor of Hepatocellular Carcinoma Cell Proliferation and Tumour Progression

Ingrid Marcq, Rémy Nyga, F Cartier et al. · PLoS ONE · 2013 · 20 citations · Full text

Medicine, Cancer Biology, Oncology +15

Cryopreservation and thawing of hematopoietic stem cell CD34-induced apoptosis through caspase pathway activation: Key role of granulocytes

Judith Desoutter, Christèle Ossart, Marie-Noëlle Lacassagne et al. · Cytotherapy · 2019 · 20 citations

Life Sciences, Cell Biology, Hematology +16

Hepatocyte SLAMF3 reduced specifically the multidrugs resistance protein MRP-1 and increases HCC cells sensitization to anti-cancer drugs

Grégory Fouquet, Véronique Debuysscher, Hakim Ouled‐Haddou et al. · Oncotarget · 2016 · 18 citations · Full text

Medicine, Oncology, Pharmacology +17

RB/PLK1-dependent induced pathway by SLAMF3 expression inhibits mitosis and control hepatocarcinoma cell proliferation

Hicham Bouhlal, Hakim Ouled‐Haddou, Véronique Debuysscher et al. · Oncotarget · 2016 · 16 citations · Full text

Medicine, Cell Biology, Oncology +17